Qatar Biomedical Research Institute (QBRI) is a national research institute within Hamad bin Khalifa University (HBKU)
. QBRI aims to improve and transform healthcare through innovation in prevention, diagnosis, and treatment of diseases affecting the Qatari population and the region.
As a disease-focused institute, QBRI concentrates on applying integrative and multidisciplinary approaches to provide novel insights into the molecular basis of the Grand Challenges of breast cancer; type 2 diabetes; neurological disorders such as autism and epilepsy; and the development of novel biomarkers, diagnostic and therapeutic strategies to facilitate early diagnosis, treatment and management of these devastating diseases towards improving personalized medicine and healthcare.
In keeping with Qatar National Health priorities and Qatar National Research Strategy, QBRI plans to establish and operate three scientific centers of excellence:
- Cancer Center.
- Diabetes Center.
- Neurological Disorders Center.
QBRI will have a flexible structure that allows it to respond to the rapidly changing medical, biomedical and health needs of Qatari society and industry. QBRI's structure also enables rapid adjustment to new scientific and technological advances, thus allowing us to remain at the forefront of biomedical research.
QBRI is committed to the training and development of the next generation of scientists and highly skilled workers by providing mentoring, advanced scientific and research training opportunities and career guidance to young scientists.